Analysts at StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX - Get Free Report) in a note issued to investors on Sunday. The brokerage set a "hold" rating on the software maker's stock.
Separately, Stephens boosted their price objective on shares of Veradigm from $7.00 to $13.00 and gave the company an "equal weight" rating in a research report on Friday, January 31st.
Get Our Latest Analysis on MDRX
Veradigm Price Performance
Shares of NASDAQ:MDRX traded down $0.15 during trading on Friday, hitting $5.15. The company's stock had a trading volume of 111,384 shares, compared to its average volume of 544,117. The company has a 50-day moving average of $6.82 and a 200-day moving average of $8.76. Veradigm has a 12 month low of $4.00 and a 12 month high of $11.80.
Veradigm Company Profile
(
Get Free Report)
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Recommended Stories
Before you consider Veradigm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.
While Veradigm currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
